25
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A Case of Focal Eosinophilic Myositis Associated with Hypereosinophilic Syndrome: A Rare Case Report

      brief-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dear Editor: Hypereosinophilic syndrome (HES) is classically defined as (i) persistent eosinophilia of >1,500 eosinophils/mm3 for >6 months; (ii) the absence of any other evident cause of eosinophilia, including allergic diseases and parasitic infections; and (iii) signs or symptoms of organ involvement by eosinophilic infiltration. Skin involvement and cutaneous findings are frequently seen in these patients. Although many other organs other than the skin can also be affected by HES, myopathies associated with HES have rarely been reported1. Here, we report a rare case of focal eosinophilic myositis associated with HES. A 49-year-old woman visited our clinic with a solitary ovoid subcutaneous tender nodule on her right palm that appeared 2 weeks before her visit (Fig. 1). She denied any history of an insect bite or trauma at the site. Routine laboratory tests showed marked elevations in the eosinophil counts (6,730/mm3; reference range, 50~500/mm3), platelet counts (562×103/mm3; reference range, 150~350×103/mm3), and C-reactive protein levels (1.97 mg/dl; reference range, 0~0.6 mg/dl); the other test results were normal. Chest radiography showed mild bilateral pleural effusion. Skin biopsy was then performed, and the patient was referred to the department of allergy to check for the cause of blood eosinophilia. Thorough medical history taking, laboratory examinations, and imaging studies excluded any known causes of hypereosinophilia such as allergic diseases, allergic drug reactions, parasitic infections, human immunodeficiency virus infections, and solid tumors. The skin biopsy showed marked infiltration of eosinophils and lymphocytes in the muscle layer, as well as in the dermis and subcutis (Fig. 2A). The patient later developed a localized erythematous patch on her left calf. The skin biopsy at that site also showed moderate infiltration of eosinophils and lymphocytes in the dermis and subcutis (Fig. 2B). The biopsy specimen was insufficient for the evaluation of the muscle layer. The diagnosis of HES was made. Considering the absence of typical histologic findings of a dermal infiltrate of eosinophils, histiocytes, and eosinophil debris between collagen bundles that form flame figures, a diagnosis of eosinophilic cellulitis was less likely. After treatment with 1 mg/kg methylprednisolone for 2 weeks, the blood eosinophil counts decreased to within the reference range and the skin lesion subsided. The lungs could be another organ involved in HES, taking into account the sudden disappearance of pleural effusion after the treatment. Recently, to overcome problems with the above-mentioned old definition, Simon et al.2 proposed a new definition for HES: (i) blood eosinophilia (>1,500 eosinophils/mm3) on at least two occasions, or evidence of prominent tissue eosinophilia associated with symptoms and marked blood eosinophilia; (ii) absence of secondary causes of eosinophilia, such as parasitic or viral infections, allergic diseases, drug-induced or chemical-induced eosinophilia, hypoadrenalism, and neoplasm. Our case is consistent with this new proposed definition of HES. To our knowledge, this is the first case of focal eosinophilic myositis associated with HES in the Korean dermatological literature3. Furthermore, the palm is a very rare site of involvement, as muscle involvement in focal eosinophilic myositis is usually restricted to the lower legs4.

          Related collections

          Most cited references5

          • Record: found
          • Abstract: found
          • Article: not found

          Refining the definition of hypereosinophilic syndrome.

          Because of advances in our understanding of the hypereosinophilic syndrome (HES) and the availability of novel therapeutic agents, the original criteria defining these disorders are becoming increasingly problematic. Here, we discuss shortcomings with the current definition of HES and recent developments in the classification of these disorders. Despite significant progress in our understanding of the pathogenesis of some forms of HES, the current state of knowledge is still insufficient to formulate a new comprehensive etiologic definition of HESs. Nevertheless, we suggest a new working definition that overcomes some of the most obvious limitations with the original definition.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Clinical overview of cutaneous features in hypereosinophilic syndrome.

            The hypereosinophilic syndromes (HES) are a heterogeneous group of disorders defined as persistent and marked blood eosinophilia of unknown origin with systemic organ involvement. HES is a potentially severe multisystem disease associated with considerable morbidity. Skin involvement and cutaneous findings frequently can be seen in those patients. Skin symptoms consist of angioedema; unusual urticarial lesions; and eczematous, therapy-resistant, pruriginous papules and nodules. They may be the only obvious clinical symptoms. Cutaneous features can give an important hint to the diagnosis of this rare and often severe illness. Based on advances in molecular and genetic diagnostic techniques and on increasing experience with characteristic clinical features and prognostic markers, therapy has changed radically. Current therapies include corticosteroids, hydroxyurea, interferon-α, the tyrosine kinase inhibitor imatinib mesylate, and (in progress) the monoclonal anti-interleukin-5 antibodies. This article provides an overview of current concepts of disease classification, different skin findings, and therapy for HES.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Eosinophilic myositis: an updated review.

              Eosinophilia-associated myopathies are clinically and pathologically heterogeneous conditions characterized by the presence of peripheral and/or muscle eosinophilia. There are at least three distinct subtypes: focal eosinophilic myositis, eosinophilic polymyositis, and eosinophilic perimyositis. Infiltrating eosinophils are not always identified in conventional muscle histologic examination, but the eosinophil major basic protein, whose extracellular diffusion is considered a hallmark of eosinophilic cytotoxicity, is usually detected by immunostaining in muscle biopsy. Whereas focal eosinophilic myositis seems to be a benign and isolated condition, and perimyositis is usually related with the inflammatory infiltrate due to fasciitis, eosinophilic polymyositis can be associated with muscular dystrophy or be a feature of multiorgan hypereosinophilic syndrome. Muscle biopsy remains the cornerstone for the diagnosis. Parasitic infections, connective tissue disorders, hematologic and non-hematologic malignancies, drugs, and toxic substances are the main etiologic agents of eosinophilia-associated myopathy. However, in some cases, no known etiologic factor is identified, and these are considered idiopathic. Glucocorticoids are the mainstay therapy in idiopathic forms. Imatinib and mepolizumab, a humanized anti-interleukin 5 monoclonal antibody, may be useful in patients with eosinophilic myositis as part of a hypereosinophilic syndrome.
                Bookmark

                Author and article information

                Journal
                Ann Dermatol
                Ann Dermatol
                AD
                Annals of Dermatology
                Korean Dermatological Association; The Korean Society for Investigative Dermatology
                1013-9087
                2005-3894
                October 2015
                02 October 2015
                : 27
                : 5
                : 629-630
                Affiliations
                Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
                Author notes
                Corresponding author: Mi Woo Lee, Department of Dermatology, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea. Tel: 82-2-3010-3460, Fax: 82-2-486-7831, miumiu@ 123456amc.seoul.kr
                Article
                10.5021/ad.2015.27.5.629
                4622906
                26512186
                539ce0c6-3b76-4ea2-b9ce-78bc76409ed8
                Copyright © 2015 The Korean Dermatological Association and The Korean Society for Investigative Dermatology

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 19 September 2014
                : 05 November 2014
                : 04 December 2014
                Categories
                Letter to the Editor

                Dermatology
                Dermatology

                Comments

                Comment on this article